EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Dilated Cardiomyopathy: A Genetic Journey from Past to Future

Noah A Newman iD, Michael A Burke iD

International Journal of Molecular Sciences · 25.10.2024 · 25 (21) · 11460

DOI: 10.3390/ijms252111460 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.10.2024. Verfasst von Noah A Newman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Genetic Predisposition to Disease. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 285 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dilated cardiomyopathy (DCM) is characterized by reduced systolic function and cardiac dilation. Cases without an identified secondary cause are classified as idiopathic dilated cardiomyopathy (IDC). Over the last 35 years, many cases of IDC have increasingly been recognized to be genetic in etiology with a core set of definitively causal genes in up to 40% of cases. While over 200 genes have been associated with DCM, the evidence supporting pathogenicity for most remains limited. Further, rapid advances in sequencing and bioinformatics have recently revealed a complex genetic spectrum ranging from monogenic to polygenic in DCM. These advances have also led to the discovery of causal and modifier genetic variants in secondary forms of DCM (e.g., alcohol-induced cardiomyopathy). Current guidelines recommend genetic counseling and screening, as well as endorsing a handful of genotype-specific therapies (e.g., device placement in LMNA cardiomyopathy). The future of genetics in DCM will likely involve polygenic risk scores, direct-to-consumer testing, and pharmacogenetics, requiring providers to have a thorough understanding of this rapidly developing field. Herein we outline three decades of genetics in DCM, summarize recent advances, and project possible future avenues for the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, DilatedGenetic Predisposition to DiseaseHumansGenetic Testing

Stichwörter der Autor:innen

LMNATTNalcohol-induced cardiomyopathyarrhythmogenic cardiomyopathydilated cardiomyopathygeneticsheart failureleft ventricular non-compactionperipartum cardiomyopathypolygenic risk score

Autor:innen und Institutionen

  • Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30322, USA.

ORCID-Profile: Noah A Newman, Michael A Burke

Zitieren

APA

Newman, N. A., & Burke, M. A. (2024). Dilated Cardiomyopathy: A Genetic Journey from Past to Future. International Journal of Molecular Sciences, 25(21), 11460. https://doi.org/10.3390/ijms252111460

Vancouver

Newman NA, Burke MA. Dilated Cardiomyopathy: A Genetic Journey from Past to Future. International Journal of Molecular Sciences. 2024;25(21):11460. doi:10.3390/ijms252111460

BibTeX
@article{Newman2024,
  author = {Newman, Noah A and Burke, Michael A},
  title = {Dilated Cardiomyopathy: A Genetic Journey from Past to Future},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {21},
  pages = {11460},
  doi = {10.3390/ijms252111460}
}
Kostenlos starten →